Psychedelics Today, Author at PsyNews.com

Home Authors Posts by admin

2176 POSTS 0 COMMENTS

https://psynews.com

PT310 – Omar Thomas – Vital Psychedelic Conversations

Could the Sonoran Desert Toad Cure Narcissism?

Mydecine Announces Reverse Stock-Split

Cybin Announces Positive CYB004 Data Demonstrating Significant Advantages Over Intravenous and...

PT309 – Jon Dennis, Esq. – Oregon’s Measure 109 and the...

Numinus to Acquire Novamind, Creating the North American Industry Leader in...

PT308 – Dr. Ido Cohen, PsyD – Vital Psychedelic Conversations

Psychedelic Bulletin: Homecoming Raises $4m Seed; Angermayer Increases atai Stake by...

Field Trip Health Ltd. Granted US Patent Covering Novel Psychedelic Molecule...

MindMed Appoints Francois Lilienthal, MD as Chief Commercial Officer

1...148149150...218 Page 149 of 218

Pα+ Psychedelic Bulletin #197: Portuguese Health-Related Professions Unite on Psychedelics; Shrooms,...

The Interdisciplinary Annotated Psychedelic Research Bibliography of 2024

Reflections on the 2025 Federal Policy Summit on Psychedelic Medicine

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin